Topic: HAE WITH NORMAL C1 INHIBITOR: HOW TO CORRECTLY DIAGNOSE AND TREAT THIS RARE TYPE OF RECURRENT ANGIOEDEMA
Date: April 4, 2024
Time: 4:00 to 5:00 pm CEST
Click HERE to register
Introduction and Moderation 5’
Thomas Buttgereit
Evolving recognition of HAE-nC1INH 15’
Anete S. Grumach
HAE-nC1INH – presentation of clinical cases 15’
Thomas Buttgereit
Estimated prevalence and treatment patterns
of HAE with normal C1 inhibitor – an US perspective 15’
Marc Riedl
Discussion and Q&A 10’
Moderated by Thomas Buttgereit
Read more news from ACARE
- January 3, 2024
Dr Thomas Buttgereit is joined by Julia Föll and Reinhardt Britz to discuss the responsibilities of working within an ACARE office, covering audit criteria and ongoing ACARE projects. Do you [...]
- September 1, 2023
Welcome to our second episode of the All Things Angioedema - Learning about Angioedema with Dr. Thomas Buttgereit Podcast Dr Thomas Buttgereit is joined by Professor Markus Magerl, leader of [...]
- September 20, 2023
Professor Jason Fok joins Dr Thomas Buttgereit to discuss angioedema updates from the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2023 and the role EAACI has in disseminating [...]